Skip to main content
Pulike Biological Engineering,Inc. logo

Pulike Biological Engineering,Inc. — Investor Relations & Filings

Ticker · 603566 ISIN · CNE1000025N0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,080 across all filing types
Latest filing 2015-11-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603566

About Pulike Biological Engineering,Inc.

http://en.pulike.com.cn/

Pulike Biological Engineering, Inc. specializes in the research, development, and production of veterinary biological products and pharmaceutical preparations. The company focuses on animal disease prevention through the manufacture of high-end vaccines, diagnostic reagents, and veterinary medicines. Its product range primarily serves the swine and poultry sectors, featuring advanced biologicals such as genetically engineered vaccines and synthetic peptide products. Pulike maintains a strong emphasis on technological innovation, utilizing national-level research platforms to develop solutions for complex animal health challenges. The company’s core activities encompass the entire value chain from basic biotechnology research to the commercialization of veterinary health solutions, aiming to improve livestock productivity and biosecurity.

Recent filings

Filing Released Lang Actions
关于获得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of a new veterinary drug registration certificate. It includes details about the new drug, regulatory approval by the Ministry of Agriculture, and the company's innovation achievements. There is no indication of financial data, management changes, voting results, or report publication. The document is a regulatory announcement about a product approval, which does not fit into financial reports or meeting materials. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2015-11-02 Chinese
关于更换持续督导保荐代表人的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the change of continuous supervision sponsors (保荐代表人) for a company's IPO process. It details the replacement of individuals responsible for ongoing supervision duties related to the company's initial public offering and listing. There is no financial data, no report attached or referenced as being published, and no mention of voting results or management changes beyond the sponsor representatives. This fits the category of a regulatory announcement about management of the IPO process, which is best classified under Regulatory Filings (RNS) as it does not fit other more specific categories like Board/Management Information (MANG) which typically involves company internal management changes, not sponsor representatives. The document length is short and it is an announcement, not a report or transcript.
2015-10-27 Chinese
2015年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2015 年第三季度报告" which translates to "2015 Third Quarter Report." It contains detailed financial data for the third quarter of 2015, including balance sheets, income statements, cash flow data, shareholder information, and management commitments. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period ending September 30, 2015. It is not a brief announcement or a certification letter but a full financial report for a period shorter than a fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2015
2015-10-22 Chinese
关于对暂时闲置自有资金进行现金管理的实施公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the implementation of cash management for temporarily idle funds, including details about purchasing bank wealth management products. It includes specifics such as product names, amounts, expected returns, risk control measures, and the impact on company operations. The document is relatively short (1942 characters) and focuses on a specific financing activity related to cash management of idle funds. It does not contain comprehensive financial statements or detailed financial performance data typical of annual or interim reports. It is not a report publication announcement since it provides substantive details about the transaction itself. The content aligns best with a Capital/Financing Update (CAP) as it relates to the company's management of funds and investment in financial products to optimize capital use.
2015-10-18 Chinese
关于子公司竞拍取得土地使用权的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by a company about its subsidiary acquiring land use rights through a bidding process. It details the land parcels, prices, and intended use, and states that the acquisition was approved by the board and shareholders. There is no financial report, earnings data, or management discussion. The document is a formal announcement of a corporate transaction related to asset acquisition but does not qualify as a full financial report or capital raising update. It is not a merger or acquisition filing, nor a regulatory certification or voting result. The best fitting category is a Regulatory Filing (RNS) as it is a general corporate announcement that does not fit other specific categories.
2015-09-21 Chinese
关于总经理增持公司股份的公告
Director's Dealing Classification · 100% confidence The document is an announcement regarding the increase in shareholding by the company's general manager, Mr. Sun Jinzhong. It details the number of shares purchased, the price, the percentage of total shares held before and after the purchase, and the future plan for further share purchases by directors and senior management. The document references compliance with securities laws and stock exchange rules. There is no financial report, earnings data, or management discussion of financial results. The content fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on shareholding changes by a director, confirming it is not a broader financial or regulatory filing.
2015-09-18 Chinese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.